Rapt Therapeutics Inc. buy me8
Start price
20.02.24
/
0%
€6.70
Target price
20.02.25
€10.00
Performance (%)
32.09%
End price
21.02.24
€8.85
Summary
This prediction ended on 21.02.24 with a price of €8.85. With a performance of 32.09% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rapt Therapeutics Inc. | - | - |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
According to me8 what are the pros and cons of Rapt Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Cons
Few uniques
Comments by me8 for this prediction
In the thread Rapt Therapeutics Inc. diskutieren
Buy Rapt Therapeutics Inc.
Kursziel gesetzt auf 10,0
In the thread Trading Rapt Therapeutics Inc.
Buy beendet